These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12451957)

  • 1. [Pharmacia and Pfizer on the CLASS trial: criticism doesn't give a fair picture of the results].
    Andersson T; Frösing R
    Lakartidningen; 2002 Oct; 99(41):4086. PubMed ID: 12451957
    [No Abstract]   [Full Text] [Related]  

  • 2. [Celebra and the CLASS trial--a scandal!].
    Lindberg M
    Ugeskr Laeger; 2002 Nov; 164(46):5407-8; author reply 5408. PubMed ID: 12469395
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new interesting study on coxib].
    Carlqvist M; Ohlén K
    Lakartidningen; 2003 Apr; 100(14):1261. PubMed ID: 12756658
    [No Abstract]   [Full Text] [Related]  

  • 4. [COX-2 inhibitors--can we rely on the articles?].
    Lindberg M
    Ugeskr Laeger; 2002 Oct; 164(42):4945-6; author reply 4946. PubMed ID: 12416082
    [No Abstract]   [Full Text] [Related]  

  • 5. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
    Håkansson J
    Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Celecoxib and the CLASS study--worse and worse...].
    Slørdal L
    Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2219. PubMed ID: 12426903
    [No Abstract]   [Full Text] [Related]  

  • 7. [Do selective COX-2-inhibitors increase the risk of myocardial infarction?].
    Otterstad JE
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3434-5. PubMed ID: 14713991
    [No Abstract]   [Full Text] [Related]  

  • 8. [Celecoxib and the CLASS trial].
    Englev E; Christensen KB
    Ugeskr Laeger; 2002 Oct; 164(41):4825-6. PubMed ID: 12407895
    [No Abstract]   [Full Text] [Related]  

  • 9. [Celecoxib and the CLASS study--a statement].
    Wibe E; Maehlum S
    Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2218. PubMed ID: 12426902
    [No Abstract]   [Full Text] [Related]  

  • 10. [Elderly patient with rheumatoid arthritis. Minimizing the peptic ulcer hemorrhage risk].
    MMW Fortschr Med; 2001 Aug; 143(31-32):46. PubMed ID: 11556192
    [No Abstract]   [Full Text] [Related]  

  • 11. NSAID toxicity: where are we and how do we go forward?
    Hawkey CJ
    J Rheumatol; 2002 Apr; 29(4):650-2. PubMed ID: 11950001
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new critical report on coxiber].
    Lindberg M
    Ugeskr Laeger; 2003 Feb; 165(7):701-2. PubMed ID: 12617054
    [No Abstract]   [Full Text] [Related]  

  • 13. Standard NSAIDs vs. COX-2 inhibitors.
    Johns Hopkins Med Lett Health After 50; 2002 Jan; 13(11):3. PubMed ID: 14727601
    [No Abstract]   [Full Text] [Related]  

  • 14. [Undesired effects of NSAIDS and coxibs].
    Fauler J
    MMW Fortschr Med; 2005 Aug; 147(31-32):31-5. PubMed ID: 16128194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pfizer urged to respond to criticism and participate in the public debate].
    Bengt J
    Lakartidningen; 2005 Feb 21-27; 102(8):574-5. PubMed ID: 15786910
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stomach-saving "Coxibs". No reason for therapeutic risks].
    MMW Fortschr Med; 2001 Jan; 143(3):56. PubMed ID: 11215349
    [No Abstract]   [Full Text] [Related]  

  • 18. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
    Einecke D
    MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
    Eisen GM; Goldstein JL; Hanna DB; Rublee DA
    Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs.
    Jüni P; Dieppe P
    Age Ageing; 2004 Mar; 33(2):100-4. PubMed ID: 14960422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.